Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Babaodan for HCC Recurrence Prevention
NCT03515369Phase 4Unknown
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- May 2018
- Primary completion
- Jan 2022
01
Overview
A Phase 4 trial of Babaodan in hepatocellular carcinoma (HCC), sponsored by Eastern Hepatobiliary Surgery Hospital. Status: unknown.
02
Drugs
Babaodan
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03515369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03515369.